This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "peripheral_axonal_degeneration#Distal Axonal Degeneration and Demyelination"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding cell types, biological processes, and causal edges, specialized to their context. Key disorder-specific substitutions: diabetic/metabolic neuropathy substitutes hyperglycemia and dyslipidemia at the trigger node; Charcot-Marie-Tooth substitutes myelin or gap-junction gene mutations and emphasizes the Schwann cell (CL:0002573) demyelinating arm; chemotherapy-induced neuropathy substitutes microtubule- or mitochondria-targeting antineoplastic agents and emphasizes the axonal-transport and mitochondrial-dysfunction amplifier; inflammatory/autoimmune neuropathy substitutes humoral or cell-mediated attack on axons and myelin. Predominantly axonal disorders may omit the Schwann cell demyelination component, and predominantly demyelinating disorders emphasize it; both converge on the length-dependent nerve-fiber dysfunction node.
Insult to Peripheral Neurons and Schwann Cells
trigger
Metabolic, genetic, toxic, or inflammatory insults injure peripheral sensory and motor neurons and the Schwann cells that ensheath their axons. The initiating lesion varies by disorder (hyperglycemia and dyslipidemia in diabetic neuropathy, myelin or gap-junction gene mutations in inherited neuropathy, microtubule- or mitochondria-targeting drugs in chemotherapy-induced neuropathy, autoantibody or cell-mediated attack in inflammatory neuropathy), but the downstream response converges on a shared program of cellular stress in peripheral neurons and glia.
Downstream
-
Axonal Transport Impairment and Mitochondrial Dysfunction
Axonal Transport Impairment and Mitochondrial Dysfunction
amplifier
Injured peripheral neurons exhibit disrupted axonal transport, mitochondrial structural and bioenergetic dysfunction, and increased oxidative stress. Because long peripheral axons depend on efficient transport of mitochondria and other cargo over great distances, this bioenergetic failure preferentially compromises the distal ends of the longest fibers and amplifies the initial insult toward overt degeneration.
Downstream
-
Distal Axonal Degeneration and Demyelination
Distal Axonal Degeneration and Demyelination
central effector
Sustained transport failure, mitochondrial dysfunction, and oxidative stress drive degeneration of the distal axon, frequently accompanied by Schwann cell demyelination. In predominantly axonal neuropathies the axon degenerates directly; in predominantly demyelinating neuropathies (e.g., demyelinating Charcot-Marie-Tooth disease) impaired Schwann cell-axon interactions and loss of myelin precede secondary axonal loss, but axonal degeneration is ultimately required for clinical symptoms. This is the central effector step converging across disorders.
Used by disorders
Behr Syndrome
as Peripheral Sensory Axon and Dorsal Column Degeneration
Downstream
-
Length-Dependent Nerve Fiber Dysfunction
Length-Dependent Nerve Fiber Dysfunction
effector
Degeneration and demyelination of the longest axons cause loss of conduction in sensory and motor nerve fibers in a length-dependent distribution, so that the distal extremities (feet before hands) are affected first. The result is failed transmission of sensory, motor, and autonomic signals along the most vulnerable peripheral fibers.
Peripheral Neuropathy
consequence
The convergent outcome is the clinical phenotype of peripheral neuropathy: distal sensory loss and numbness, neuropathic pain, and motor weakness, typically in a symmetric glove-and-stocking distribution reflecting the length-dependent degeneration of the longest peripheral nerve fibers. The relative contribution of sensory, motor, and autonomic deficits varies by underlying disorder, but the convergent phenotype is length-dependent peripheral nerve dysfunction.